A stereospecific transport system for leucine, isoleucine, and valine in Escherichia coli K-12 has been described (2, 3, 14) .
A kinetic analysis of the transport of leucine in E. coli K-12 shows that at external amino acid concentrations around 10-7 to 10-M, the major route of entry is via a single transport system, although other systems serve to some extent (14) . Evidence for heterogeneity of leucine entry is provided by the inability of isoleucine to inhibit leucine entry completely and by the distinctly biphasic kinetics of entry of all three branched-chain amino acids (15) . A binding protein (LIV-binding protein) has been isolated from the shock fluid. This binding activity appears to be associated with the LIVtransport system (13) . Growth of E. coli in the presence of leucine causes a simultaneous decrease in the synthesis of the binding proteins and leucine transport activity (13) . A second but minor transport system specific for leucine and a corresponding leucine specific-binding protein (L-binding protein) in E. coli have been identified by Furlong and Weiner (5 Oxender, Fed. Proc. 29:341, 1970) . Cells that have been subjected to osmotic-shock treatment or have been grown in the presence of leucine have extremely low levels of the binding proteins, yet retain low but significant levels of transport activity for leucine, isoleucine, and valine. Transport activity for these amino acids has also been meaAured in membrane vesicle preparations of E. coli by Lombardi and Kaback (9) . Guardiola and Iaccarino have used valine resistance to isolate several types of mutants that have defects in transport of branched-chain amino acids (6) .
The present report is an attempt to describe more completely the heterogeneity in the transport of the branched-chain amino acids by using kinetic and genetic approaches. Portions of this The LIV-binding protein and the leucinespecific binding protein are also repressed under these conditions. If wild-type E. coli cells are grown in the presence of 50 mg of L-leucine per liter, the transport of leucine is reduced more than 90%. However, there is essentially a complete loss of all binding proteins for leucine. The nonrepressed transport activity represents a small but saturable component of leucine entry corresponding to the high Km component of leucine entry (LIV-II system). A reciprocal plot of the data is presented in Fig. 2 . The data can now be described by single Km and Vmax values, which are listed in Table 2 . The low Km component of entry (LIV-I) present in Fig. 1 is missing in cells grown on leucine (Fig. 2) . i 1;
D-Leucine transport activity is also repressed in lO 10 strain EO 0303 grown in the presence of L-leucine, whereas the Dlu strain EO 0312 has derepressed D-leucine transport activity (12) . rate of uptake of Osmotic-shock treatment. When the cells in the absence are subjected to osmotic-shock treatment, all nthhe abseennceof detectable binding protein activity is removed.
When the transport activity of shock-treated strains EO 0303, EO 0312, or EO 0319 was obtained for the parental strain EO 0303. These data can not be described by a single set of constants because the plot produced is biphasic. Similar biphasic plots were obtained for the uptake of isoleucine and valine into strain EO 0303. The data were analyzed by applying methods indicated by Winter and Christensen (18) and reported in detail by Neal (10) Table  2 . For the purpose of identification, we will refer to the low Km (0.2 MM) component of leucine entry as the LIV-I transport system and the high Km (-2 AuM) component as the LIV-II transport system. The increased transport activity for D-leucine in strain EO 0312 has been reported previously (12) .
Repressed transport activity. The LIV-I component of leucine entry is sensitive to osmotic-shock treatment and to repression when the cells are grown in the presence of leucine. Leucine specific transport. Additional evidence for more than one component of L-leucine entry in E. coli K-12 is shown in Fig. 3 . The data presented in Fig. 3 were obtained by measuring the initial rate of 1.0-jiM-labeled L-leucine entry with increasing concentrations of unlabeled Lleucine or L-isoleucine added. After isoleucine has reached its maximum inhibitory action on leucine uptake, a saturable component of leucine entry remains. This leucine specific component constitutes less than 10% of the entry of leucine at 1.0 jiM. The Km value for the specific leucine transport, 0.2 MM, was determined by measuring leucine transport in the presence of 1 mM L-isoleucine. This Km value is similar to the low Km value identified above as the LIV-I system. Therefore, entry of leucine via the L-system is included in the low Km-LIV-I transport system. When the uptake of L-isoleucine was measured in these same cells, the addition of unlabeled L-leucine completely inhibited the L-isoleucine uptake, producing the same inhibitory action as that shown by adding unlabeled L-isoleucine. These latter findings are interpreted to indicate the absence of L-isoleucine specific transport systems in E. coli K-12. ( Fig. 1) , has greatly increased leucine transport activity as compared with the parental strain EO 0303 (Fig. 4) . In contrast to findings obtained with strain EO 0312, leucine uptake in strain EO 0319 is still repressible. When the initial rate of uptake of labeled L-leucine (1 AM) into strain EO 0319 was measured in the presence of increasing concentrations of unlabeled isoleucine, the results shown in Fig. 5 strain EO 0319 occurs by the leucine-specific transport system, as opposed to less than 10% in wild-type E. coli (Fig. 3) .
Evidence for heterogeneity in the L-leucilne binding activity released by osmotic-shock treatment. E. coli EO 0319 cells grown on glycerol were harvested in late log phase, washed, and subjected to osmotic-shock treatment in the cold according to the method described previously (11) . The supernatant fluid from the shock treatment was subjected to diethylaminoethyl (DEAE) chromatography as described previously (13) . The binding activity was measured by equilibrium dialysis after concentration of the material eluted from a DEAE-cellulose column. Figure 6 shows the leucine binding activity in the presence of increasing concentrations of unlabeled isoleucine or leucine. About 50% of the leucine binding activity obtained from EO 0319 is leucine specific, which is in ageement with data presented earlier for leucine-specific uptake in strain EO 0319 (Fig. 5) . These findings confirm the previously reported isolation and purification of a leucine-specific binding protein by Weiner and Furlong (5).
As we indicated in an earlier report (G. When the binding material from strain EO 0319 leu+ was eluted from a DEAE-cellulose column by using a shallow, linear NaCl gradient according to the method of Furlong and Weiner (5), three binding activities were eluted. The elution pattern of the proteins is presented in Fig. 7 . The various binding proteins are identified in the figure. The bars along the abscissa indicate the areas where antigenic activity to the antibodies prepared against the LIV-binding protein was observed. Fractions corresponding to each of the three binding activities were pooled and concentrated. The specific activity and the specificity of binding for each of the three proteins were measured ( Table 3) . As the data indicate, the first fraction to be eluted from the column is the LIV-binding activity. The second fraction contains binding activity for all three branched chain amino acids but shows a preference for isoleucine over leucine. This minor binding activity is referred to as the I-binding activity. The third fraction contains the L-binding activity that binds leucine and its analogue, trifluoroleucine.
Specificity of LIV-I and LIV-II. The component of L-leucine transport that can be correlated with the LIV-binding protein (LIV-I system) has the highest affinity for L-leucine, L-isoleucine, and L-valine, but it apparently does serve for several other neutral amino acids. Table 4 Table 4 (right column). Figure 8 presents the inhibitory action of L-alanine on the transport of L-isoleucine in several strains grown in the presence or absence of L-leucine. Isoleucine was used because it is taken up by LIV-I and LIV-II, but not by the leucine specific system. Isoleucine transport in strains EO 0323 and EO 0303 grown on leucine, which occurs mainly through the LIV-II system, is insensitive to L-alanine inhibition (curves 1 and 2, respectively). The LIV-I system, which is also present in the parental strain (EO 0303) grown without leucine (curve 3) and in the derepressed transport mutant (EO 0312) grown in the presence (curve 5) or absence (curve 4) of leucine, is sensitive to L-alanine inhibition. The specificity of the partially purified LIVbinding activity that was removed by osmotic shock treatment is described in Table 5 . This preparation still contains small amounts of the leucine-specific binding activity. The inhibitory action of L-threonine, L-alanine, and L-serine on the LIV-binding protein shows that the broad specificity of this protein is consistent with the broad specificity of the LIV-I transport system. The L-binding protein has been shown to be specific for L-leucine and its analogue trifluoroleucine (5). The minor binding activity identified as the isoleucine-binding protein shows a preference for isoleucine but also binds leucine and valine. It is not clear at present whether a separate transport system is associated with this binding protein.
Defective transport mutants. The mutant strains EO 0312 and EO 0319 have increased transport activities for D-leucine, as well as for the L-isomer, which apparently accounts for their ability to utilize D-leucine as a source of L-leucine. By using these strains, we applied a penicillin selection in the presence of D-leucine to isolate leucine transport mutants. Several mutants were isolated that showed greatly decreased D-and L-leucine transport activity. The initial rates of entry of L-leucine into two of these mutants are shown in Fig. 9 when the binding proteins were isolated from these mutants.
When one of the mutants (EO 0323) was subjected to osmotic-shock treatment, the total binding activity obtained was the same as that from the parent strain EO 0312. The chromatographic and antigenic properties of the binding proteins from the mutant were also similar to those of the starting strain (EO 0312). The Kd values obtained from L-leucine and L-isoleucine for the LIV-binding protein were indistinguishable from those obtained with the proteins from strain EO 0312. The transport defect in this mutant appears to be in some component other than the binding protein. The second mutant (EO 0321) was also subjected to osmotic shock treatment and the binding material chromatographed on DEAE-cellulose, with results presented in Table 3 . The chromatographic behavior and the yield of the LIV-binding protein and the I-binding protein were similar to those of the parental strain; however, the L-binding protein was eluted in a slightly later fraction. The presence of the protein in the eluate was determined by its antigenic activity to antibody; however, as shown in Table 3 , no leucinespecific binding activity would be detected. These data are consistent with the failure to observe leucine-specific transport activity in strain EO 0321 (data not shown).
DISCUSSION
Several early reports of the transport of the branched-chain amino acids into E. coli suggested a common transport system (2, 3). Indeed, the major portion of the transport of leucine, isoleucine, and valine occurs by a common transport system that has been called the LIV-I transport system (14) . From the present studies it now appears that two additional systems serve to mediate the entry of leucine into E. coli. A membrane-bound transport system that is insensitive to osmotic shock treatment and is not repressible by growth of the cells in the presence of leucine has been identified (LIV-II system). The third system is specific for leucine.
LIV-I system. The majority of leucine uptake into E. coli K-12 occurs by a low Km (0.2 gM) transport system that is shared by all three branched-chain amino acids. The LIV-binding protein that has been isolated from these cells appears to be associated with the LIV-I transport system. Early reports from this laboratory on the specificity of the LIV-I system indicated that this system served only for the branchedchain amino acids. A similar specificity was reported for the corresponding LIV-binding pro- tein. The present studies provide evidence suggesting a somewhat broader specificity for both the LIV-I transport system and the LIV-binding protein. First of all, studies on the inhibition of leucine entry into wild-type strains (Table 2) indicate that a component of entry of L-alanine, L-threonine, and possibly L-serine appears to be mediated by the LIV-I system. In addition, the LIV-binding protein shows this same broad specificity (Table 3) . In another study in our laboratory on alanine transport in E. coli (16) , it was observed that there are at least two components of alanine uptake. One route of L-alanine entry corresponds to the LIV-I transport system because it is subject to inhibition by leucine, to repression by growth of the cells in the presence of leucine, and to reduction by osmotic shock treatment. The isolation of leucine transport mutants that also show a partial loss of L-alanine transport (data not shown) suggests that the two amino acids share a common system. These data suggest that the LIV-I transport system and the LIV-binding protein serve for a large variety of neutral amino acids. From the limited number of studies with D-leucine uptake, it appears that it shares the same systems that serve for the L Growth of the cells in the presence of leucine does not alter the high Km component of entry, suggesting that it is not subject to control by repression. The transport mutants described in this report appear to retain the LIV-II system, although they have defective LIV-I and L-transport systems. The LIV-II system is more specific than the LIV-I system. L-Alanine and L-threonine do not inhibit L-leucine uptake in repressed cells nor in osmotically shocked cells where the major entry route is the LIV-II system. The LIV-II system appears to be firmly attached to the membrane and can function in the absence of detectable LIV-binding protein This high Ki, low Vmax system perhaps accounts for the transport activity for leucine, isoleucine, and valine measured in membrane vesicle preparations of E. coli by Lombardi and Kaback (9) . L-system. A leucine-specific transport system and corresponding binding protein was described by Furlong and Weiner (5) . The L-system normally comprises a minor component of leucine entry (10 to 15%), but certain conditions of growth appear to lead to increased levels. In kinetic plots of leucine uptake, the entry via the L-system is included in the LIV-I system because they both have the same Km values and are sensitive to osmotic shock and repression by leucine. The Dlu mutant strain EO 0319 shows a significant increase in leucinespecific transport and L-binding protein. The leucine analogue trifluoroleucine inhibits the binding of leucine of the L-binding protein and can be used to determine amounts of L-binding activity in a mixture of binding proteins.
The transport mutant strain EO 0321 appears to have an altered L-binding protein that shows altered chromatographic, antigenic, and binding properties. This mutant is being studied further to examine the relationship of the Ltransport system to the LIV-transport system.
The similarities in the kinetic properties, the antigenic cross-reactivity of the binding proteins, and the common regulatory features of the LIV-I system and the L-system suggest that they may be very closely related. Recently 
